Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Bates

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|November 13, 2003
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificityR W Robey, Y Honjo, K Morisaki, et al.
American Journal of Obstetrics and Gynecology|January 1, 1986
Coronary artery disease in diabetic pregnanciesE A Reece, J F Egan, D R Coustan, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomasS E Bates, C Y Shieh, L A Mickley, et al.
The Journal of Biological Chemistry|October 25, 1989
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agentsL A Mickley, S E Bates, N D Richert, et al.
The Journal of Urology|June 24, 1999
Intrinsic drug resistance in primary and metastatic renal cell carcinomaE Gamelin, S D Mertins, J T Regis, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1987
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogeneR B Dickson, A Kasid, K K Huff, et al.
Cancer Detection and Prevention|January 1, 1991
Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control womenK Stromberg, M Duffy, C Fritsch, et al.
Journal of Cell Science|May 12, 2000
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)T Litman, M Brangi, E Hudson, et al.
Cancer Research|December 22, 1999
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cellsM Brangi, T Litman, M Ciotti, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|November 13, 2003
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificityR W Robey, Y Honjo, K Morisaki, et al.
American Journal of Obstetrics and Gynecology|January 1, 1986
Coronary artery disease in diabetic pregnanciesE A Reece, J F Egan, D R Coustan, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Molecular targets in the National Cancer Institute drug screenS E Bates, A T Fojo, J N Weinstein, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomasS E Bates, C Y Shieh, L A Mickley, et al.
The Journal of Biological Chemistry|October 25, 1989
Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agentsL A Mickley, S E Bates, N D Richert, et al.
The Journal of Urology|June 24, 1999
Intrinsic drug resistance in primary and metastatic renal cell carcinomaE Gamelin, S D Mertins, J T Regis, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1987
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogeneR B Dickson, A Kasid, K K Huff, et al.
Cancer Detection and Prevention|January 1, 1991
Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control womenK Stromberg, M Duffy, C Fritsch, et al.
Journal of Cell Science|May 12, 2000
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)T Litman, M Brangi, E Hudson, et al.
Cancer Research|December 22, 1999
Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cellsM Brangi, T Litman, M Ciotti, et al.
Pageof 11